GEHA · Zepbound and Wegovy coverage

Does GEHA cover Zepbound or Wegovy?

Last updated

Yes, with prior authorization, as non-preferred drugs on most GEHA plans.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Yes, with prior authorization, as non-preferred drugs on most GEHA plans. GEHA covers Wegovy, Zepbound, Saxenda, Foundayo and generic liraglutide for weight loss on its High, Standard, HDHP and Elevate Plus plans for members who meet its prior authorization requirements. In its words: "For members enrolled in the High, Standard, HDHP and Elevate Plus plans, the following GLP-1s are covered by the plan for members who meet the prior authorization (PA) requirements:" (GEHA, Pharmacy coverage for weight loss GLP-1 medications, updated 10/01/2026, geha.com, read Nov 17, 2026). On those plans the brands are non-preferred medications; on GEHA's Elevate plan the same document lists them as preferred. In its words: "Please note, Wegovy, Saxenda, Zepbound, and Foundayo are non-preferred medications." (GEHA, Pharmacy coverage for weight loss GLP-1 medications, updated 10/01/2026, geha.com, read Nov 17, 2026). OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. In its words: "Plans will continue to cover at least one GLP-1 anti-obesity medication and at least two oral anti-obesity medications. For 2027, all FEHB and PSHB Carriers will require documented participation in an evidence-based intensive behavioral therapy (IBT) program both prior to and during treatment with anti-obesity medications." (U.S. Office of Personnel Management, Federal Benefits Open Season Highlights, 2027 Plan Year, opm.gov, read Nov 17, 2026).

Questions

GEHA, Zepbound and Wegovy: common questions

Does GEHA cover Zepbound for weight loss?

Yes, with prior authorization, as non-preferred drugs on most GEHA plans. GEHA covers Wegovy, Zepbound, Saxenda, Foundayo and generic liraglutide for weight loss on its High, Standard, HDHP and Elevate Plus plans for members who meet its prior authorization requirements. In its words: "For members enrolled in the High, Standard, HDHP and Elevate Plus plans, the following GLP-1s are covered by the plan for members who meet the prior authorization (PA) requirements:" (GEHA, Pharmacy coverage for weight loss GLP-1 medications, updated 10/01/2026, geha.com, read Nov 17, 2026). On those plans the brands are non-preferred medications; on GEHA's Elevate plan the same document lists them as preferred. In its words: "Please note, Wegovy, Saxenda, Zepbound, and Foundayo are non-preferred medications." (GEHA, Pharmacy coverage for weight loss GLP-1 medications, updated 10/01/2026, geha.com, read Nov 17, 2026). OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. In its words: "Plans will continue to cover at least one GLP-1 anti-obesity medication and at least two oral anti-obesity medications. For 2027, all FEHB and PSHB Carriers will require documented participation in an evidence-based intensive behavioral therapy (IBT) program both prior to and during treatment with anti-obesity medications." (U.S. Office of Personnel Management, Federal Benefits Open Season Highlights, 2027 Plan Year, opm.gov, read Nov 17, 2026). Zepbound not covered: the cash price at your dose

Does GEHA cover Wegovy for weight loss?

Yes, with prior authorization, as non-preferred drugs on most GEHA plans. GEHA covers Wegovy, Zepbound, Saxenda, Foundayo and generic liraglutide for weight loss on its High, Standard, HDHP and Elevate Plus plans for members who meet its prior authorization requirements. In its words: "For members enrolled in the High, Standard, HDHP and Elevate Plus plans, the following GLP-1s are covered by the plan for members who meet the prior authorization (PA) requirements:" (GEHA, Pharmacy coverage for weight loss GLP-1 medications, updated 10/01/2026, geha.com, read Nov 17, 2026). On those plans the brands are non-preferred medications; on GEHA's Elevate plan the same document lists them as preferred. In its words: "Please note, Wegovy, Saxenda, Zepbound, and Foundayo are non-preferred medications." (GEHA, Pharmacy coverage for weight loss GLP-1 medications, updated 10/01/2026, geha.com, read Nov 17, 2026). OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. In its words: "Plans will continue to cover at least one GLP-1 anti-obesity medication and at least two oral anti-obesity medications. For 2027, all FEHB and PSHB Carriers will require documented participation in an evidence-based intensive behavioral therapy (IBT) program both prior to and during treatment with anti-obesity medications." (U.S. Office of Personnel Management, Federal Benefits Open Season Highlights, 2027 Plan Year, opm.gov, read Nov 17, 2026). Wegovy not covered: the cash price at your dose

What do Zepbound and Wegovy cost if GEHA does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 11, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). Every GLP-1's cash price without insurance

Does Medicaid cover Zepbound or Wegovy?

It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.